Dear Colleagues
It is our pleasure to invite you to attend the Roche-sponsored symposium “Latest advances in diagnostic and treatment options for the COVID-19 pandemic: overcoming challenges in a rapidly evolving environment” at the virtual ECCMID 2021 congress.
During this one-hour session, we will examine the latest clinical data related to COVID-19 management across diagnosis and treatment options.
Professor Maria Vehreschild will contextualise patient decision-making using the latest diagnostic options to assist in the assessment and stratification of patients.
This will be followed by Professor François Raffi discussing the latest data on COVID-19 therapeutics across the clinical spectrum.
There will also be the opportunity to join our expert faculty in discussing the current and future outlook for managing COVID-19.
We hope you are able to join us for this engaging exploration of the impact that new diagnostic and treatment opportunities are having against this evolving global pandemic.
ESCMID-Appointed Chair: Vitali Sintchenko University of Sydney, Australia |
Symposium Chair: Albert Osterhaus TiHo Hannover, Germany |
13:15 – 13:20 |
Welcome and introductions
Vitali Sintchenko University of Sydney, Australia
Professor Albert Osterhaus TiHo Hannover, Germany
|
13:20 – 13:40 |
Case-based decision making: using SARS-CoV-2 diagnostic results
Maria Vehreschild University Hospital Frankfurt, Germany
|
13:40 – 14:00 |
Treatment options for COVID-19: current landscape and future outlook
François Raffi Nantes University Hospital, France
|
14:00 – 14:10 |
Discussion and Q&A
All faculty
|
14:10 – 14:15 |
Closing remarks
Albert Osterhaus Vitali Sintchenko
|
This is a non-promotional educational meeting intended for HCPs outside the USA and may include scientific information about investigational compounds that are not approved or valid in your jurisdiction.
M-XX-00005685